{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn biochemical assays, apicalist inhibits the p110\u03b1 subunit of PI3K (ic50=4.6 nM) more than 50-fold compared to other class I PI3K isoforms (e.g., p110\u03b2ic50=1156nm, p110\u03b4 ic50=290 nM, p110\u03b3ic50=250 nM) and is inactive against most other kinases (Fritsch C et al, (2014) Characterization of the novel and specific PI k\u03b1 inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials [ characterization of novel specific PI3k\u03b1 inhibitor NVP-BYL719 and development of clinical trial patient stratification strategies ]. \nIn biochemical assays, apicalist inhibits the p110\u03b1 subunit of PI3K (ic50=4.6 nM) \np110\u03b2ic50=1156nm \np110\u03b4 ic50=290 nM \np110\u03b3ic50=250 nM"}
{"final_json": [{"molecule_name": "apicalist", "protein_target_name": "p110\u03b1 subunit of PI3K", "binding_metric": "ic50", "value": "4.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "apicalist", "protein_target_name": "p110\u03b2", "binding_metric": "ic50", "value": "1156", "unit": "nm", "is_logarithmic": false}, {"molecule_name": "apicalist", "protein_target_name": "p110\u03b4", "binding_metric": "ic50", "value": "290", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "apicalist", "protein_target_name": "p110\u03b3", "binding_metric": "ic50", "value": "250", "unit": "nM", "is_logarithmic": false}]}
